跳至主要内容
临床试验/IRCT2016080818745N11
IRCT2016080818745N11招募中早期 1 期

The expression level alterations of miRNAs 21, 155, 10b and Let-7a, and matrix metalloproteinases 1, 2, 9, 11 and 13 as biomarkers in response to surgery and chemotherapy in blood plasma of breast cancer patients

Tehran University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
早期 1 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 70 years(—)
性别
Female

入选标准

  • The patients with breast cancer; With written informed consent; 30-70 years old patients; The breast cancer patients in stages 2 and 3.
  • Exclusion criteria: The patients with opioid addiction; The patients with the history of rheumatoid arthritis; The patients with the history of cancer.

排除标准

  • 未提供

研究者

相似试验